AiQuant Research
Proprietary, Self-Funded
AiQuant Research is QPG’s proprietary quantamental research effort, focused on developing and validating investment research through a disciplined, self-funded process grounded in quantitative methods and fundamental analysis.
What It Is
This workstream represents QPG’s long-term proprietary research effort and internal capital development process. Current work is centered on structured hypothesis formation, testing, and refinement rather than outside capital activity.
The objective is to build a research process that is evidence-based, repeatable, and resilient over time, with particular emphasis on healthcare, biotechnology, and other information-sensitive markets that reward domain depth.
Current Focus
- Market hypothesis development and evaluation
- Backtesting and signal validation
- Healthcare and biotechnology research
- Application of machine learning to market and scientific data
- Risk management and staged internal capital testing
Current Stage
Research Phase (Self-Funded)
Role Inside QPG
AiQuant Research serves as QPG’s core quantamental research engine, supported by operating cash flow and developed through a staged, evidence-based process.
Over time, this work is intended to develop into a more mature internal capital allocation process built on validated research, disciplined execution, and operational learning.
QPG does not manage third-party capital or provide regulated investment advisory services. Any trading activity referenced is conducted solely with internal capital.